A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objective of this study is to measure the efficacy of ABT-SLV187 in subjects with advanced Parkinson\'s disease.
Epistemonikos ID: 5f2cd9ebb272ffd6dd8f2efb45f8bbebaf833507
First added on: May 11, 2024